Evaluation of a 3D Printed Silicone Oral Cavity Cancer Model for Surgical Simulations.

head and neck oncology oral cavity cancer surgical simulation

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 28 03 2024
revised: 16 04 2024
accepted: 21 04 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Adequate surgical margins are essential in oral cancer treatment, this is, however, difficult to appreciate during training. With advances in training aids, we propose a silicone-based surgical simulator to improve training proficiency for the ablation of oral cavity cancers. A silicone-based tongue cancer model constructed via a 3D mold was compared to a porcine tongue model used as a training model. Participants of varying surgical experience were then asked to resect the tumors with clear margins, and thereafter asked to fill out a questionnaire to evaluate the face and content validity of the models as a training tool. Eleven participants from the Otolaryngology-Head and Neck Surgery unit were included in this pilot study. In comparison to the porcine model, the silicone model attained a higher face (4 vs. 3.6) and content validity (4.4 vs. 4.1). Tumor consistency was far superior in the silicone model compared to the porcine model (4.1 vs. 2.8,

Identifiants

pubmed: 38793031
pii: jpm14050450
doi: 10.3390/jpm14050450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Princess Margaret Cancer Centre
ID : 1001

Auteurs

Donovan Eu (D)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Department of Otolaryngology-Head and Neck Surgery-Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Department of Otolaryngology-Head and Neck Surgery, National University Health Systems, Singapore 119228, Singapore.

Michael J Daly (MJ)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.

Stefano Taboni (S)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Department of Otolaryngology-Head and Neck Surgery-Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neuroscience, "Azienda Ospedale Università di Padova" University of Padua, 35122 Padua, Italy.

Axel Sahovaler (A)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Department of Otolaryngology-Head and Neck Surgery-Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
Department of Oral and Maxillofacial Surgery, University College London Hospitals, London NW1 2BU, UK.

Ashley N Gilbank (AN)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.

Jonathan C Irish (JC)

Guided Therapeutic (GTx) Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Department of Otolaryngology-Head and Neck Surgery-Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.

Classifications MeSH